表紙
市場調查報告書

個人化醫療/精密醫療現況

The State of Personalized/ Precision Medicine

出版商 GlobalData 商品編碼 917039
出版日期 內容資訊 英文 119 Pages
訂單完成後即時交付
價格
Back to Top
個人化醫療/精密醫療現況 The State of Personalized/ Precision Medicine
出版日期: 2019年10月31日內容資訊: 英文 119 Pages
簡介

本報告提供全球個人化醫療/精密醫療市場最新形勢相關分析,個人化醫療/精密醫療的特徵,及各個方面 (患者,製藥企業,醫療制度等) 的潛在的影響度,目前已上市產品,臨床實驗的進展,今後的市場趨勢預測 (機會與課題),產業相關人員今後應採取策略等資訊彙整,為您概述為以下內容。

第1章 序論

第2章 摘要整理

第3章 個人化醫療/精密醫療概要

  • 定義
  • 個人化醫療/精密醫療定義
  • KOL (有學識者) 及保險付款者的見解
  • 個人化醫療的特徵
  • 生物標記種類與診斷方法

第4章 對醫療市場的個人化醫療的影響度

  • 個人化醫療 - 醫療的影響:患者的情況
  • 個人化醫療的優點 - 患者的情況
  • 醫療上的未滿足需求的,個人化醫療所扮演的角色
  • 個人化醫療 - 醫療的影響:藥物開發企業的情況
  • 個人化醫療的優點 - 藥物開發企業的情況
  • 個人化醫療 - 醫療的影響:醫療制度的情況

第5章 主要已上市產品

第6章 開發中產品

第7章 個人化醫療的投資

第8章 資本交易形勢

第9章 市場機會與課題

第10章 價格設定,醫療費償付,法規策略

第11章 個人化醫療 - 新趨勢

第12章 主要分析結果:概要

13. Appendix

目錄
Product Code: GDHCHT027

Personalized and precision medicines use information about a person's genes, proteins, and environment to prevent, diagnose, and treat disease. In cancer, personalized medicine uses specific information about an individual to help diagnose, plan treatment, find out how well treatment is working, or make a prognosis. This report covers current and future challenges for the development and launch of these medicines, focusing on challenges with transitioning these therapies from bench to bedside and demonstrating efficacy in order to secure reimbursement.

Scope

  • GlobalData's The State of Personalized/Precision Medicine combines key opinion leader insight with in-house analyst expertise and research to provide an insight-rich look at personalized and precision medicine in the US, Europe, and Asia.
  • Components of the report include:
  • Definition of Personalized/Precision Medicine-Key attributes of personalized/precision medicine, examining and contrasting definitions by regulatory bodies and KOL respondents.
  • Personalized Medicine-Impact on Healthcare-Key factors to impacting healthcare for patients and stakeholders providing respondent mix by region and organization size.
  • Marketed products-Detailed information is provided for key personalized/precision medicines, including case studies for marketed oncology and rare disease therapeutics.
  • Pipeline products-The diverse Phase III pipeline is presented, including detailed information on key candidate's mechanism of action and clinical trial parameters.
  • Investment in Personalized Medicine-Investment in personalized medicine by indication and clinical trial design and approaches are presented, with case studies for three ongoing oncology trials being considered.
  • Market Opportunities and Challenges-Key areas of opportunity and roadblocks in developing, launching, and gaining reimbursement are analyzed by geography, company size, and seniority level.
  • Emerging Trends-Critical new trends, including the use of advanced digital technologies, are examined.

Reasons to buy

  • Develop business strategies by understanding the global trends shaping and driving the personalized/precision medicines market
  • Formulate effective sales and marketing strategies by understanding the competitive landscape of various competitors in a niche therapeutic space.
  • Identify areas of unmet need within the personalized/precision market to help drive research and development towards future market opportunities.
  • Gain insights to help plan and design your clinical trials.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
  • Identify key funding and partnership strategies.

Table of Contents

1. Preface

  • 1.1 Table of Concents
  • 1.2 Abbreviations
  • 1.3 Related Reports
  • 1.4 Upcoming Related Reports

2. Executive Summary

3. Overview of Personalized/Precision Medicine

  • 3.1 Definition
  • 3.2 Definition of Personalized/Precision Medicine
  • 3.3 KOL and Payer Perspecive
  • 3.4 Key Attributes of Personalized Medicine Therapy
  • 3.5 Types of Biomarkers and Diagnostics

4. Impact of Personalized Medicine on Healthcare

  • 4.1 Personalized Medicine - Impact on Healthcare - Patients
  • 4.2 Advantages of Personalized Medicine - Patients
  • 4.3 Role of Personalized Medicine in Clinical Unmet Needs
  • 4.4 Personalized Medicine - Impact on Healthcare - Drug Developers' Perspective
  • 4.5 Advantages of Personalized Medicine to Drug Developers
  • 4.6 Personalized Medicine - Impact on Healthcare - Health System

5. Key Marketed Products

6. Pipeline Products

7. Investment in Personalized Medicine

8. Deal-Making Landscape

9. Market Opportunities and Challenges

10. Pricing, Reimbursement, and Regulatory Strategy

11. Personalized Medicine - Emerging Trends

12. Summary of Key Findings

13. Appendix

Back to Top